ATLANTA, April 10, 2024 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD). The lawsuit alleges Defendants made materially false and misleading statements and/or failed to disclose material adverse information, including allegations that: (i) the Company heavily discounted almost every device it sells; (ii) demand for the Company’s products was driven by InMode’s willingness to discount its products; (iii) the Company violated FDA regulations by engaging in off-label marketing and promoting products for treatment of indications for which they lack FDA approval; and (iv) the Company violated FDA regulations by failing to timely report injuries caused by its devices.
If you bought InMode shares between June 4, 2021 and October 12, 2023, and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888)-508-6832 or, you may visit the firm’s website at www.holzerlaw.com/case/inmode/ to learn more.
The deadline to ask the court to be appointed lead plaintiff in the case is April 15, 2024.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com
- Dan IVES AI Revolution ETF Surpasses $100 Million AUM Within First Trading Week of Wedbush Fund Advisers’ Inaugural Offering - June 13, 2025
- Local Entrepreneur Brings First of Two AtWork Locations to Greenville-Spartanburg Market - June 13, 2025
- Flow Cytometry Market Hits US$10.3B by 2032: Why Every Lab Needs a FACS Flow Cytometer? - June 13, 2025
